Close

Anti-KRT18 DNA-encoded mAb (DMAb), pVAX1 (DMAb-1471-CQ)


All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This product is the plasmid containing an encoded anti-KRT18 DMAb sequence. The plasmid can drive transcription and in vivo translation of the desired antibody.

  Add to Cart

Specifications

  • Target
  • KRT18
  • Vector Name
  • pVAX1
  • Vector Description
  • pVAX1 was originally designed for the development of DNA vaccines. Its eukaryotic DNA sequences limited to the expression of desired sequence so that minimize the possibility of chromosomal integration. This vector has been widely used for the construction of DMAb plasmid.
  • Vector Promoter
  • CMV
  • Vector Tag or Fusion
  • Untagged
  • Delivery Method
  • Transfection
  • Cloning Method
  • Restriction Enzyme ⁄ MCS
  • Constitutive or Inducible System
  • Constitutive
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term.
  • Background
  • DNA-encoded mAb (DMAb) technology is a novel approach for a direct in vivo production of desired biologically active immunoglobulins according to the plasmid DNA delivery into tissue where the delivered plasmid containing an encoded antibody sequence. Compared with the traditional mAb, DMAb can be functionally equivalent with additional advantages such as expression profiles, glycosylation, as well as no reliance on in vivo tissue culture and costly or time-consuming production systems. The DMAb technology may provide a novel, simple, less frequent, cost-effective approach for therapeutics.

Target

  • Entrez Gene ID
  • 3875
Sub CAT. DMAb Clone DMAb Host Target Species DMAb Isotype DMAb Immunogen  
DMAb-1472-CQ Ks18.04 Mouse IgG1 Cytoskeleton preparation of epidermal carcinoma cell line A431
DMAb-1473-CQ DA7 Mouse Human IgG1, κ Human breast cancer PMC 42 cells
DMAb-1474-CQ DC10 Mouse Human IgG1 Human breast cancer PMC 42 cells
DMAb-1475-CQ DE-K18 Mouse IgG1, κ Cytoskeletal preparation extracted from the human vulvar squamous carcinoma cell line A431
DMAb-1476-CQ KRT18/1190 Mouse IgG1, κ Recombinant human KRT18 protein
DMAb-1477-CQ KRT18/834 Mouse Human IgG1 Recombinant Full length human KRT18 protein
DMAb-1478-CQ KRT18/836 Mouse IgG1 Recombinant human KRT18 protein
DMAb-1479-CQ LC18N Mouse Human IgG1 Synthetic pepide of N terminus of human keratin 18 (NH2-SFTTRSTFSC)
DMAb-1480-CQ LDK18 Mouse IgG1 Synthetic peptide of human keratin 18 (CSETNDTKVLRH-COOH)
DMAb-1481-CQ RCK106 Mouse Human IgG1 Cytokeratins from the human bladder carcinoma cell line T24
DMAb-1482-CQ RGE53 Mouse IgG1 A cytoskeletal preparation of cells
DMAb-1483-CQ SPM265 Mouse Human IgG1 PMC-42 human breast carcinoma cells
DMAb-1484-CQ SPM510 Mouse Human IgG1, κ Human breast cancer PMC 42 cells
DMAb-1486-CQ M6 Mouse Human IgG2a Keratin 18 (K18) fragments purified from human carcinomas
DMAb-1487-CQ M30 Mouse Human IgG2b Keratin 18 (K18) fragments purified from supernatant from human carcinoma cell line WiDr CCL218
DMAb-1490-CQ B23.1 Mouse Human IgG1 PMC-42 human breast carcinoma cells
DMAb-1491-CQ RM279 Rabbit Human IgG A peptide corresponding to the N-terminus of human Cytokeratin 18
DMAb-0886-WJ C-04 Mouse IgG1 Cytoskeleton preparation of epidermal carcinoma cell line A431
DMAb-1473-CQ DA7 Mouse Human IgG1, κ Human breast cancer PMC 42 cells were used as immunogen to generate the Cytokeratin 18 (CK18) antibody
DMAb-1474-CQ DC10 Mouse Human IgG1 Human breast cancer PMC 42 cells were used as immunogen to generate the Keratin 18 antibody
DMAb-0896-WJ Ks 18.04 Mouse IgG1 Human cytokeratin 18
DMAb-1480-CQ LDK18 Mouse Human IgG1, κ
DMAb-0903-WJ CK-18 Mouse IgG1 The human epidermal carcinoma A-431 and MCF-7 human breast cancer cell lines
DMAb-0905-WJ CY90 Mouse Human IgG1 Tissue / cell preparation (human epidermal carcinoma and MCF-7 human breast cancer allcells)
DMAb-0907-WJ DEK-18 Mouse IgG1
DMAb-1478-CQ KRT18/836 Mouse IgG1 Recombinant human KRT18 protein
DMAb-0916-WJ M9 Mouse IgG1

Customer Reviews and Q&As

There are currently no customer reviews or questions for Anti-KRT18 DNA-encoded mAb (DMAb), pVAX1 (DMAb-1471-CQ). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.